← Back to Search

Energy Drinks on Sleep and Heart Health

N/A

Recruiting

Led By Anna Svatikova, MD, PhD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up approximately 24 hours

Awards & highlights

Study Summary

This trial looks at how energy drinks affect sleep and heart health.

Who is the study for?

This trial is for adults over 18 who are generally healthy, not on any medications (except birth control pills), non-smokers, and have no history of heart or thyroid disease. They should not be sensitive to caffeine, pregnant, regular energy drink consumers, late sleepers, recent travelers across time zones, shift workers, suspected of having sleep apnea or with a BMI over 35.Check my eligibility

What is being tested?

The study aims to compare the effects on sleep quality and cardiovascular health between an energy drink and a placebo drink that has no caffeine. Participants will consume one of these drinks in a controlled environment to assess changes in their sleep patterns and heart responses.See study design

What are the potential side effects?

Potential side effects may include disrupted sleep patterns such as difficulty falling asleep or staying asleep; increased heart rate; elevated blood pressure; jitteriness; anxiety; digestive discomfort due to the ingredients in the energy drink.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ approximately 24 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~approximately 24 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Atrial arrhythmias

Changes in sleep architecture

Changes in sleep continuity

+3 more

Secondary outcome measures

Sympathetic activation quantified by changes in plasma dopamine

Sympathetic activation quantified by changes in plasma epinephrine

Sympathetic activation quantified by changes in plasma norepinephrine

+3 more

Other outcome measures

Changes in resting blood pressure

Changes in resting heart rate

Trial Design

2Treatment groups

Experimental Treatment

Group I: Placebo drink first, than energy drinkExperimental Treatment2 Interventions

Subjects will consume two 16-oz identical looking placebo drink before sleep at the fist study visit, then consume two 16-oz energy drinks before sleep for the second study visit.

Group II: Energy drink first, then placebo drinkExperimental Treatment2 Interventions

Subjects will consume two 16-oz energy drinks before sleep for the first study visit, then consume two 16-oz identical looking placebo drink before sleep at the second study visit.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,210 Previous Clinical Trials

3,766,928 Total Patients Enrolled

Anna Svatikova, MD, PhDPrincipal InvestigatorMayo Clinic

Media Library

Caffeine Research Study Groups: Energy drink first, then placebo drink, Placebo drink first, than energy drink

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it feasible to join this scientific experiment at the moment?

"Affirmative. Information found on clinicaltrials.gov demonstrates that this medical trial, which was first made available to the public on September 1st 2022, is presently enrolling patients. There are 30 volunteers needed from one location in total."

Answered by AI

What is the cohort size of this research endeavor?

"Affirmative. The information on clinicaltrials.gov affirms that this experiment is presently enlisting participants, as it was initially posted on September 1st 2022 and last revised on the 12th of same month. Thirty volunteers are needed at a single site for completion of the trial."

Answered by AI

What tangible outcomes is this experiment aiming to realize?

"The primary metric of the trial, assessed over two nights, will be QT segment. Secondary objectives for analysis comprise total urine epinephrine secretion to quantify sympathetic activation, plasma norepinephrine while supine and finally a measure of total urine dopamine secretion."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effects of Energy Drinks on Sleep and Cardiovascular Health

Anna Svatikova 2022. "Effects of Energy Drinks on Sleep and Cardiovascular Health". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05503732.